Independent of tumor characteristics, such as histology and grades, higher expressions of SHH, PTCH1, PTCH2, and GLI1 have shown beneficial prognostic influence, whereas GLI2, GLI3, and SUFU are correlated with adverse clinical outcomes in OC patients. This evidence concerns the gene PTCH2 and neoplasm.